KMTS: Q1 revenue up 60% to $31M; FY27 guidance raised to $141M with gross margin target mid-70%
Revenue grew 60% year-over-year to $31M with gross margin expanding to 56.5%. FY27 guidance was raised to $141M (48% growth), driven by market expansion, share gains, and improved in-network mix. Gross margin target increased to mid-70% over the next few years.Based on Kestra Medical Technologies…
5%. FY27 guidance was raised to $141M (48% growth), driven by market expansion, share gains, and improved in-network mix. Based on Kestra Medical Technologies…